University of Tokyo Researchers Advance Artificial Heart Research

The team is utilizing PTC Creo to help design and simulate a Total Artificial Heart.

Researchers at the University of Tokyo‘s Graduate School of Medicine are using PTC Creo Software to develop a Total Artificial Heart. The modeling capabilities of the platform are advancing the team’s efforts to develop an implantable device by 2016.

Total Artificial Heart The Total Artificial Heart is able to completely replace the damaged heart.

The university started using Pro/ENGINEER to create models of its artificial heart design in 2003 and upgraded to Creo in 2012. The team uses Creo to simulate blood flow and model component machining. According to the company, Creo also supports daily collaboration across the team by enabling the creation of easy-to-understand graphical materials with cross-sections of 3D models and animations.

Heart Model Researchers at the University of Tokyo implemented PTC software to model its Total Artificial Heart.

“PTC Creo has become an essential part of our development environment and a standard solution for the team in engineering an artificial heart,” said Takashi Isoyama, Ph.D., assistant professor, Department of Biomedical Engineering, the University of Tokyo Graduate School of Medicine and a member of the artificial heart research and development team. PTC Creo has successfully supported the processes of designs and studies in addition to component machining, and enables our team to make significant advances as we reach our goals.”

For more information, visit University of Tokyo and PTC.

Sources: Press materials received from the company and additional information gleaned from the company’s website.

Share This Article

Subscribe to our FREE magazine, FREE email newsletters or both!

Join over 90,000 engineering professionals who get fresh engineering news as soon as it is published.


About the Author

DE Editors's avatar
DE Editors

DE’s editors contribute news and new product announcements to Digital Engineering.
Press releases may be sent to them via [email protected].

Follow DE
#13271